OR WAIT null SECS
May 18, 2023
Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.
May 12, 2023
Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.
April 28, 2023
The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.
April 04, 2023
A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.
March 02, 2023
Stockpiling excess inventory is no longer enough to respond to supply chain volatility.
Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.
Good distribution practices ensure appropriate physical storage, distribution, and supply chain security, says Siegfried Schmitt, vice president, Technical, at Parexel.
February 03, 2023
Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.
January 03, 2023
Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023?
December 02, 2022
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.